Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Taiga Nishihori"'
Autor:
Miguel-Angel Perales, Soyoung Kim, Roy F. Chemaly, Marcie L. Riches, Randy Taplitz, Ephraim J. Fuchs, Christopher E. Dandoy, Christopher G. Kanakry, Taiga Nishihori, Min Chen, Sagar S. Patel, Stefan O. Ciurea, Anurag K. Singh, Richard T. Maziarz, Hillard M. Lazarus, Jean A. Yared, Maxwell M. Krem, Per Ljungman, Muhammad Bilal Abid, Brian D. Friend, Rizwan Romee, Krishna V. Komanduri, Siddhartha Ganguly, Asad Bashey, Carolyn Mulroney, John R. Wingard, Miguel Pérez, Scott R. Goldsmith
Publikováno v:
Br J Haematol
British journal of haematology, vol 194, iss 1
British journal of haematology, vol 194, iss 1
Community respiratory viral infections (CRVIs) are associated with pulmonary function impairment, alloimmune lung syndromes and inferior survival in human leucocyte antigen (HLA)-matched allogeneic haematopoietic stem cell transplant (HCT) recipients
Autor:
Asad Bashey, Carolyn Mulroney, Roy F. Chemaly, Paul Castillo, Ephraim J. Fuchs, Christopher G. Kanakry, Hillard M. Lazarus, Hongtao Liu, Per Ljungman, Jeffery J. Auletta, Stefan O. Ciurea, Jennifer A. Kanakry, Miguel-Angel Perales, Muhammad Bilal Abid, Randy Taplitz, Rizwan Romee, Richard Masiarz, Soyoung Kim, Amer Beitinjaneh, Marcie L. Riches, Christopher E. Dandoy, Taiga Nishihori, Min Chen, Krishna V. Komanduri, Kristin Page, Sunita Nathan, Miguel Angel Diaz, Maxwell M. Krem, Scott R. Goldsmith, Siddhartha Ganguly
Publikováno v:
Blood
Prior studies suggest increased cytomegalovirus (CMV) infection after haploidentical donor transplantation with posttransplant cyclophosphamide (HaploCy). The role of allograft source and posttransplant cyclophosphamide (PTCy) in CMV infection is unc
Autor:
Melhem Solh, Biju George, Mariam H Johnson, Vikas Gupta, Daniel J. Weisdorf, Michael R. Grunwald, Wael Saber, Andrew St. Martin, Minoo Battiwalla, Christopher G. Kanakry, Rohtesh S. Mehta, Mary Eapen, Corey Cutler, Christopher Bredeson, Ryotaro Nakamura, Filippo Milano, Taiga Nishihori, Edward A. Copelan, Asad Bashey, Alberto Mussetti, Hany Elmariah, Mei-Jie Zhang
Publikováno v:
Blood Adv
We compared outcomes in 603 patients with myelodysplastic syndrome (MDS) after HLA-haploidentical relative (n = 176) and HLA-matched unrelated (n = 427) donor hematopoietic cell transplantation (HCT) from 2012 to 2017, using the Center for Internatio
Autor:
Siddhartha Ganguly, Andrew Daly, Tracey A. O'Brien, Melhem Solh, Steven Z. Pavletic, Rammurti T. Kamble, Leslie Lehmann, Tao Wang, Takanori Teshima, Amer Beitinjaneh, Miguel Pérez, Mahmoud Aljurf, Mukta Arora, John L. Wagner, Medhat Askar, Marjolein van der Poel, Madan Jagasia, Rabi Hanna, Alvaro Urbano-Ispizua, Ravi Vij, Armin Rashidi, Taiga Nishihori, Catherine J. Lee, A. Samer Al-Homsi, Vijaya Raj Bhatt, Michael T. Hemmer, Roger Strair, Hannah Choe, Joseph Pidala, Jeffery J. Auletta, Hisham Abdel-Azim, Vaibhav Agrawal, Shahinaz M. Gadalla, Stefan O. Ciurea, S Spellman, Margaret L. MacMillan, Rodrigo Martino, Jean-Yves Cahn, Mitchell S. Cairo, Basem M. William, Rizwan Romee, Jean A. Yared, Navneet S. Majhail, Annie Im, Usama Gergis, Mohamed A. Kharfan-Dabaja, Richard F. Olsson, Sagar S. Patel, Baldeep Wirk, Peiman Hematti, Michael Byrne, Asad Bashey, Hemant S. Murthy, Betty K. Hamilton, Muna Qayed, Pooja Khandelwal, Robert Peter Gale, Saurabh Chhabra, Gerhard C. Hildebrandt, Jan Cerny, Sachiko Seo, Roger H. Herzig, Nosha Farhadfar, Deepesh Lad, Hélène Schoemans, Akshay Sharma, Tim Prestidge, Lazaros J. Lekakis, Daniel J. Weisdorf, Paul Castillo, Miguel-Angel Perales
Publikováno v:
Biol Blood Marrow Transplant
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVH
Autor:
Ayman Saad, Baldeep Wirk, Usama Gergis, Melhem Solh, Muna Qayed, Robert Peter Gale, Leo F. Verdonck, Rohtesh S. Mehta, Niketa Shah, Mahmoud Aljurf, Gerhard C. Hildebrandt, Sachiko Seo, Tim Prestidge, Thomas R. Spitzer, Vijaya Raj Bhatt, David I. Marks, Attaphol Pawarode, Taiga Nishihori, Mukta Arora, Hisham Abdel-Azim, Miguel Angel Diaz, Joseph Pidala, Ami J. Shah, Margaret L. MacMillan, Michael T. Hemmer, James Gajewski, Medhat Askar, Hemalatha G. Rangarajan, Ibrahim Ahmed, Yoshihiro Inamoto, Jean A. Yared, Stephen R. Spellman, Carrie L. Kitko, Richard F. Olsson, Christopher Bredeson, Amin M. Alousi, Tao Wang, Takanori Teshima, Kirk R. Schultz, Kirsten M. Williams, Jeff Szer, Bipin N. Savani, Daniel R. Couriel, Pooja Khandelwal, Shahinaz M. Gadalla, Saurabh Chhabra, Parinda A. Mehta, Olle Ringdén, Shernan G. Holtan, Navneet S. Majhail, Peiman Hematti, Jeffery J. Auletta, Daniel J. Weisdorf, John E. Wagner
Publikováno v:
Blood Advances. 3:1441-1449
We report graft-versus-host disease (GVHD)-free relapse-free survival (GRFS) (a composite end point of survival without grade III-IV acute GVHD [aGVHD], systemic therapy–requiring chronic GVHD [cGVHD], or relapse) and cGVHD-free relapse-free surviv
Autor:
Yoshihiro Inamoto, Harry C. Schouten, Amin M. Alousi, Ravi Vij, David I. Marks, John E. Wagner, Joseph Pidala, Joseph H. Antin, Margaret L. MacMillan, Gérard Socié, Ayman Saad, Shahrukh K. Hashmi, Luciano J. Costa, Mukta Arora, Hisham Abdel-Azim, Hélène Schoemans, Michael T. Hemmer, Robert Peter Gale, Stephen R. Spellman, Daniel R. Couriel, Saurabh Chhabra, Taiga Nishihori, Sachiko Seo, Alvaro Urbano-Ispizua, Bipin N. Savani, Brenda W. Cooper, Muna Qayed, Robert J. Hayashi, Leo F. Verdonck, Mark R. Litzow, Jean A. Yared, Usama Gergis, Navneet S. Majhail, Betty K. Hamilton, Mahmoud Aljurf, Robert K. Stuart, Rammurti T. Kamble, Leslie Lehmann, Takanori Teshima, Ying Liu, Rodrigo Martino, Jean-Yves Cahn, Olle Ringdén, Peiman Hematti, Melhem Solh, Dennis Dong Hwan Kim
Publikováno v:
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Biology of Blood and Marrow Transplantation, 25(1), 73-85. Elsevier Science
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Biology of Blood and Marrow Transplantation, 25(1), 73-85. Elsevier Science
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
The combination of a calcineurin inhibitor (CNI) such as tacrolimus (TAC) or cyclosporine (CYSP) with methotrexate (MTX) or with mycophenolate mofetil (MMF) has been commonly used for graft-versus-host disease (GVHD) prophylaxis after reduced-intensi
Autor:
Leona Holmberg, Hisham Abdel-Azim, Ran Reshef, Shahrukh K. Hashmi, Joseph Pidala, Sung Wong Choi, Baldeep Wirk, Taiga Nishihori, Usama Gergis, Richard F. Olsson, Michael Byrne, Daniel R. Couriel, Bipin N. Savani, Shahinaz M. Gadalla, Tracey A. O'Brien, Nelson J. Chao, Amer Beitinjaneh, Jean A. Yared, Leo F. Verdonck, Ayman Saad, Michael T. Hemmer, Lucie M. Turcotte, Yoshihiro Inamoto, Ibrahim Ahmed, Mukta Arora, Jennifer M. Knight, Maxim Norkin, Zachariah DeFilipp, Ravi Vij, Mary M. Horowitz, Michael R. Verneris, Rammurti T. Kamble, Leslie Lehmann, Tao Wang, Harry C. Schouten, Amin M. Alousi, Robert Peter Gale, Sachiko Seo, Margaret A. MacMillan, David Buchbinder, Stephen R. Spellman, Natalie S. Callander, Melhem Solh, Peiman Hematti, Zachariah A. McIver
Publikováno v:
Bone marrow transplantation
Correspondence: Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation
Autor:
Hisham Abdel-Azim, Reinhold Munker, Wael Saber, Jean-Yves Cahn, Melhem Solh, Gerhard C. Hildebrandt, Joseph Pidala, Taiga Nishihori, Robert Peter Gale, Richard F. Olsson, Brian C. Shaffer, Hillard M. Lazarus, Sachiko Seo, Miguel Angel Diaz, Yener Koc, O Ringdén, Mahmoud Aljurf, Hemant S. Murthy, Mark R. Litzow, Neil Palmisiano, Brenda M. Sandmaier, Corey Cutler, John L. Wagner, Andrew Daly, Jacob M. Rowe, Sagar S. Patel, Anurag K. Singh, Keith Stockerl-Goldstein, Nasheed Hossain, Amer Beitinjaneh, Shahrukh K. Hashmi, Mohamed A. Kharfan-Dabaja, Nandita Khera, Javier Bolaños-Meade, Leo F. Verdonck, Nelli Bejanyan, Nosha Farhadfar, Asad Bashey, Michael R. Grunwald, Theresa Hahn, Sunita Nathan, Marcos de Lima, Edward A. Copelan, David A. Rizzieri, Betul Oran, Daniel J. Weisdorf, Rebecca L. Olin, Mehdi Hamadani, Ryotaro Nakamura, Ashish Bajel, Michael Byrne, Kirk R. Schultz, Jong Wook Lee, Siddhartha Ganguly, Armin Rashidi, Christopher G. Kanakry, Hai-Lin Wang, Edmund K. Waller, Amer Assal, Stefan O. Ciurea, Mei-Jie Zhang, Mitchell S. Cairo, Minoo Battiwalla, Rodrigo Martino, Vijaya Raj Bhatt, Joseph P. McGuirk, Mary Lynn Savoie, H. Kent Holland, Johan Maertens, Rizwan Romee
HLA-haploidentical hematopoietic cell transplantation (Haplo-HCT) using posttransplantation cyclophosphamide (PT-Cy) has improved donor availability. However, a matched sibling donor (MSD) is still considered the optimal donor. Using the Center for I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeefe0489193228a914e8491f2e15162
https://lirias.kuleuven.be/handle/20.500.12942/687585
https://lirias.kuleuven.be/handle/20.500.12942/687585
Autor:
Dennis Dong Hwan Kim, Jean-Yves Cahn, Olle Ringdén, Joseph Pidala, Margaret L. MacMillan, J. Schriber, Leo F. Verdonck, Mahmoud Aljurf, Joseph H. Antin, Robert K. Stuart, Ayman Saad, Mitchell S. Cairo, Eneida R. Nemecek, Ying Liu, David I. Marks, Daniel R. Couriel, Saurabh Chhabra, Stephen R. Spellman, Usama Gergis, Mukta Arora, Betty K. Hamilton, Christopher E. Dandoy, Taiga Nishihori, Yoshihiro Inamoto, Sung Won Choi, Bipin N. Savani, Amin M. Alousi, Christopher Bredeson, Edmund K. Waller, Gérard Socié, Robert Peter Gale, Navneet S. Majhail, Luciano J. Costa, Sachiko Seo, Mona Wirk, Rammurti T. Kamble, Takanori Teshima, Michael T. Hemmer, Peiman Hematti
Publikováno v:
Biol Blood Marrow Transplant
Combination therapy with a calcineurin inhibitor (CNI), such as cyclosporine (CSA) or tacrolimus (Tac), and methotrexate (MTX) or mycophenolate mofetil (MMF) is a widely used approach to graft-versus-host disease (GVHD) prevention. Data on the compar
Autor:
Tim Prestidge, Michael R. Grunwald, Michael A. Pulsipher, Martin S. Tallman, Wael Saber, Biju George, Baldeep Wirk, Leo F. Verdonck, Daniel J. Weisdorf, Hisham Abdel-Azim, Brenda M. Sandmaier, Amer Beitinjaneh, Rodrigo Martino, Geoffrey L. Uy, Joseph P. McGuirk, Moshe Yeshurun, Maxim Norkin, Marcos de Lima, Mei-Jie Zhang, Mitchell S. Cairo, Bipin N. Savani, Brenda W. Cooper, Sachiko Seo, Taiga Nishihori, Haydar Frangoul, Christopher E. Dandoy, Jean-Yves Cahn, David I. Marks, Siddhartha Ganguly, Hai-Lin Wang, Miguel Angel Diaz, William R. Drobyski, Veronika Bachanova, Rammurti T. Kamble, Matthew J. Wieduwilt, Shahram Mori, Jacob M. Rowe, Michael Byrne, Jane L. Liesveld, Asad Bashey, Bruce M. Camitta
Publikováno v:
Yeshurun, M, Weisdorf, D, Rowe, J M, Tallman, M S, Zhang, M J, Wang, H L, Saber, W, de Lima, M, Sandmaier, B M, Uy, G, Kamble, R T, Cairo, M S, Cooper, B W, Cahn, J Y, Ganguly, S, Camitta, B, Verdonck, L F, Dandoy, C, Diaz, M A, Savani, B N, George, B, Liesveld, J, McGuirk, J, Byrne, M, Grunwald, M R, Drobyski, W R, Pulsipher, M A, Abdel-Azim, H, Prestidge, T, Wieduwilt, M J, Martino, R, Norkin, M, Beitinjaneh, A, Seo, S, Nishihori, T, Wirk, B, Frangoul, H, Bashey, A, Mori, S, Marks, D I & Bachanova, V 2019, ' The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia ', Blood Advances, vol. 3, no. 4, pp. 670-680 . https://doi.org/10.1182/bloodadvances.2018027003
Allogeneic hematopoietic cell transplant is a potential curative therapy for acute lymphoblastic leukemia (ALL). Delineating the graft-versus-leukemia (GVL) effect as a function of graft-versus-host disease (GVHD) offers the potential to improve surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d887eb66af93c0a2da388e91226c872
https://hdl.handle.net/1983/dea9ca4b-9c8b-4d09-879b-0c8a9681708b
https://hdl.handle.net/1983/dea9ca4b-9c8b-4d09-879b-0c8a9681708b